Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of MRSA Nasal Screen Implementation on Duration of Therapy and Cost Associated With Vancomycin Use.

NCT07748143 is registered in ClinicalTrials.gov with Methodist Health System as lead sponsor.

NCT NCT07748143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07748143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of MRSA Nasal Screen Implementation on Duration of Therapy and Cost Associated With Vancomycin Use.
Lead sponsor
Methodist Health System
Phase
Observational
Overall status
Completed
Start date
October 1, 2019
Completion date
June 10, 2026
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mrsa